Trial Profile

A retrospective single-center study to determine efficacy of neuromuscular blocking agents and reversal agents during anaesthesia on early removal of chest tube drainage after video-assisted thoracoscopic surgery

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 01 Sep 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Cisatracurium besilate (Primary) ; Neostigmine (Primary) ; Rocuronium bromide (Primary) ; Sugammadex (Primary)
Indications Neuromuscular blockade
Focus Therapeutic Use

01 Sep 2022 New trial record
26 Aug 2022 Primary endpoint has been met (Duration of chest-tube drainage after surgery) , according to Results published in the British Journal of Anaesthesia
26 Aug 2022 Results published in the British Journal of Anaesthesia

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com